Equity Overview
Price & Market Data
Price: $5.63
Daily Change: -$0.06 / 1.07%
Range: $5.40 - $6.00
Market Cap: $155,354,224
Volume: 17,953
Performance Metrics
1 Week: 10.83%
1 Month: -12.98%
3 Months: -9.63%
6 Months: 24.01%
1 Year: -39.07%
YTD: -10.92%
Company Details
Employees: 32
Sector: Health technology
Industry: Pharmaceuticals: major
Country: United States
Details
Fennec Pharmaceuticals Inc. operates as a commercial stage biopharmaceutical company in the United States. The company's product candidate includes PEDMARK, a formulation of sodium thiosulfate for the prevention of platinum-induced ototoxicity in pediatric cancer patients. It sells its products through regional pediatric oncology specialists and medical science liaisons. The company was formerly known as Adherex Technologies Inc. and changed its name to Fennec Pharmaceuticals Inc. in September 2014. Fennec Pharmaceuticals Inc. was incorporated in 1996 and is based in Research Triangle Park, North Carolina.